Search

Your search keyword '"Pocock, SJ."' showing total 571 results

Search Constraints

Start Over You searched for: Author "Pocock, SJ." Remove constraint Author: "Pocock, SJ."
571 results on '"Pocock, SJ."'

Search Results

1. The Clinical outcomes, healthcare resource utilization, and related costs (COHERENT) model. Application in heart failure patients

3. Empagliflozin in heart failure with a preserved ejection fraction

4. Trial Design Principles for Patients at High Bleeding Risk Undergoing PCI: JACC Scientific Expert Panel

5. Mortality After Repeat Revascularization Following PCI or CABG for Left Main Disease The EXCEL Trial

6. Cardiovascular and renal outcomes with empagliflozin in heart failure

7. Baseline characteristics of patients with heart failure with preserved ejection fraction in the EMPEROR-Preserved trial

10. Analysis of How Emergency Physicians' Decisions to Hospitalize or Discharge Patients With Acute Heart Failure Match the Clinical Risk Categories of the MEESSI-AHF Scale

11. Effect of Barthel Index on the Risk of Thirty-Day Mortality in Patients With Acute Heart Failure Attending the Emergency Department: A Cohort Study of Nine Thousand Ninety-Eight Patients From the Epidemiology of Acute Heart Failure in Emergency Departments Registry

12. The Usefulness of the MEESSI Score for Risk Stratification of Patients With Acute Heart Failure at the Emergency Department

13. Effect of Sitagliptin on Cardiovascular Outcomes in Type 2 Diabetes

14. Everolimus-eluting stents or bypass surgery for left main coronary artery disease

15. Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes

16. New medicinal products for chronic heart failure: advances in clinical trial design and efficacy assessment

17. Diagnostic and Prognostic Implications of Coronary Flow Capacity: A Comprehensive Cross-Modality Physiological Concept in Ischemic Heart Disease

18. Differing prognostic value of pulse pressure in patients with heart failure with reduced or preserved ejection fraction: results from the MAGGIC individual patient meta-analysis

19. Aspirin does not reduce the clinical benefits of the mineralocorticoid receptor antagonist eplerenone in patients with systolic heart failure and mild symptoms: an analysis of the EMPHASIS-HF study.

20. Eplerenone in patients with systolic heart failure and mild symptoms

21. Addition of Salmeterol versus Doubling the Dose of Beclomethasone in Children with Asthma

22. Smoking in pregnancy may cause childhood wheeze

23. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: Guidelines for reporting of observational studies

24. Rosiglitazone RECORD study: glucose control outcomes at 18 months

25. Effect of long-acting nifedipine on mortality and cardiovascular morbidity in patients with stable angina requiring treatment (ACTION trial): randomised controlled trial

26. A comparison of two methods for the estimation of precision with incomplete longitudinal data, jointly modelled with a time-to-event outcome

27. Impact of missing data due to selective dropouts in cohort studies and clinical trials

29. Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration

30. Compliance and adverse event withdrawal: their impact on the west of Scotland Coronary Prevention Study

31. One year treatment with salmeterol compared with beclomethasone in children with asthma

32. Peak flow variation in childhood asthma: Relationship to symptoms, atopy, airways obstruction and hyperresponsiveness

33. SHORT-TERM EFFECTS OF AIR-POLLUTION ON DAILY MORTALITY IN ATHENS - A TIME-SERIES ANALYSIS

35. EFFECTS OF 22 MONTHS OF TREATMENT WITH INHALED CORTICOSTEROIDS AND OR BETA-2-AGONISTS ON LUNG-FUNCTION, AIRWAY RESPONSIVENESS, AND SYMPTOMS IN CHILDREN WITH ASTHMA

37. Reporting of noninferiority and equivalence randomized trials: extension of the CONSORT 2010 statement.

40. Dexmedetomidine vs midazolam or propofol for sedation during prolonged mechanical ventilation: two randomized controlled trials.

43. Prognostic modeling of individual patient risk and mortality impact of ischemic and hemorrhagic complications: assessment from the Acute Catheterization and Urgent Intervention Triage Strategy trial.

44. Antithrombotic strategies in patients with acute coronary syndromes undergoing early invasive management: one-year results from the ACUITY trial.

45. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies.

47. Rosiglitazone evaluated for cardiovascular outcomes--an interim analysis.

48. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.

49. Routine upstream initiation vs deferred selective use of glycoprotein IIb/IIIa inhibitors in acute coronary syndromes: the ACUITY Timing trial.

50. Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in Non-Insulin-Dependent Diabetes Mellitus (ASPEN)

Catalog

Books, media, physical & digital resources